Under the Rader: Viking Stock Gains on Weight-Loss Study
Dow Jones
Sep 22
Shares of VikingTherapeutics surged roughly 30% Tuesday morning after the company reported its experimental weight-loss shot could help people keep the weight off at less-frequent doses. The move put the stock on pace for its biggest one-day percentage gain since February 2024.
In the study, patients who switched from weekly to every-other-week dosing kept off an average of 90% of the weight they initially lost. Those who switched to a once-monthly maintenance dose maintained an average of 85% of their weight loss, compared with roughly 61% in the placebo group.
"The efficacy is impressive, though preserving these reductions with fewer injections provides the more differentiated finding," Citi analyst Geoff Meacham said.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.